Some of the content on this page has been created using generative AI.
What is it about?
The study systematically evaluated AI-based techniques from 2018 to 2025 for analyzing pancreatic tumors using CT images, identifying 33 eligible studies from an initial pool of 236 records across databases like PubMed and Scopus. The review categorized these studies into four themes: AI-driven segmentation for tumor localization, deep learning-based tumor classification, CT-based radiomics and feature-driven analysis, and early detection models. The research emphasized the effectiveness of AI in enhancing diagnostic accuracy through segmentation, classification, and hybrid techniques, while also focusing on datasets, evaluation metrics, and clinical applicability. The findings highlighted significant advancements in machine learning and deep learning architectures, such as CNNs and attention-based methodologies, which improved pancreas segmentation and tumor detection. Despite progress, challenges such as anatomical variability, class imbalance, and model interpretability in multi-institutional studies persist, complicating large-scale clinical translation. Furthermore, the study identified ongoing challenges with integrating AI into clinical workflows, domain adaptation, and ensuring consistent model performance across different imaging platforms.
Featured Image
Why is it important?
This study is important as it addresses the critical challenge of early diagnosis in pancreatic ductal adenocarcinoma (PDAC), one of the most lethal cancers due to its late-stage detection and limited imaging sensitivity. By systematically evaluating AI-based techniques for analyzing CT scans from 2018 to 2025, the research highlights advancements in diagnostic accuracy, offering potential for earlier disease identification. Such innovations are crucial for reducing mortality rates associated with pancreatic cancer, enhancing patient outcomes, and integrating AI into clinical diagnostic workflows for improved healthcare delivery. Key Takeaways: 1. AI-Driven Segmentation: The study underscores the effectiveness of AI in localizing pancreatic tumors through advanced segmentation techniques, which significantly improve the precision of tumor detection in CT imaging. 2. Deep Learning Classification: The research highlights the successful application of deep learning models to classify pancreatic tumors, demonstrating enhanced performance in distinguishing between different tumor types and stages. 3. Radiomics and Early Detection: By leveraging CT-based radiomics and feature-driven analysis, the study presents promising approaches for early PDAC detection, addressing the challenges of subtle imaging features and anatomical variability, thus facilitating earlier and more accurate diagnosis.
AI notice
Read the Original
This page is a summary of: A Systematic Review on Leveraging Artificial Intelligence for Pancreatic Cancer Diagnosis: Review, Premier Journal of Science, March 2026, Premier Science,
DOI: 10.70389/pjs.100268.
You can read the full text:
Contributors
Be the first to contribute to this page







